Gene · 200186
Papers1,653
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,653
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The functionally conserved human lncRNA motif GULF lowers glucose and lipid levels in obese mice. | J Clin Invest | 2025 | 40955662 | PubTator, text mining | PubMed |
| The fungal STRIPAK complex: Cellular conductor orchestrating growth and pathogenicity. | PLoS Pathog | 2025 | 40953055 | PubTator, text mining | PubMed |
| Adipose tissue aging as a risk factor for metabolic organ abnormalities: mechanistic insights and the role of exercise interventions. | Lipids Health Dis | 2025 | 40898292 | PubTator, text mining | PubMed |
| Regulatory role of E3 ubiquitin ligases in multiple myeloma: from molecular mechanisms to therapeutic strategies. | Front Cell Dev Biol | 2025 | 40809696 | PubTator, text mining | PubMed |
| MAPK Signaling in the Interplay Between Oxidative Stress and Autophagy. | Antioxidants (Basel) | 2025 | 40563296 | PubTator, text mining | PubMed |
| The central signaling pathways related to metabolism-regulating hormones of the gut-brain axis: a review. | J Transl Med | 2025 | 40500780 | PubTator, text mining | PubMed |
| Dynamic Regulation of CYP19A1 Promoter Region under Control of CREB Family Members in Endometrial Tissues of Women with Endometriosis: A Case-Control Study. | Int J Fertil Steril | 2025 | 40200772 | PubTator, text mining | PubMed |
| Correction: DNAJB1-PRKACA Fusion Drives Fibrolamellar Liver Cancer through Impaired SIK Signaling and CRTC2/p300-Mediated Transcriptional Reprogramming. | Cancer Discov | 2025 | 40170541 | PubTator, text mining | PubMed |
| SIK1 inhibits IL-1β-stimulated cartilage apoptosis and inflammation in vitro through the CRTC2/CREB1 signaling. | Open Life Sci | 2025 | 40059873 | PubTator, text mining | PubMed |
| Comprehensive Gene Expression Analysis in Papillary Thyroid Carcinoma Reveals a Transcriptional Profile Associated with Reduced Radioiodine Avidity. | Endocr Pathol | 2025 | 39982585 | PubTator, text mining | PubMed |
| The TRPM7 chanzyme in smooth muscle cells drives abdominal aortic aneurysm in mice. | Nat Cardiovasc Res | 2025 | 39953275 | PubTator, text mining | PubMed |
| CRTC3 restricts SARS-CoV-2 replication and is antagonized by CREB. | Virol Sin | 2025 | 39736320 | PubTator, text mining | PubMed |
| Oxyberberine Inhibits Hepatic Gluconeogenesis via AMPK-Mediated Suppression of FoxO1 and CRTC2 Signaling Axes. | Phytother Res | 2025 | 39522954 | PubTator, text mining | PubMed |
| DNAJB1-PRKACA Fusion Drives Fibrolamellar Liver Cancer through Impaired SIK Signaling and CRTC2/p300-Mediated Transcriptional Reprogramming. | Cancer Discov | 2025 | 39326063 | PubTator, text mining | PubMed |
| Pharmacology of Aging: Drosophila as a Tool to Validate Drug Targets for Healthy Lifespan. | Aging Biol | 2024 | 39346601 | PubTator, text mining | PubMed |
| CREB activates the MafA promoter through proximal E-boxes and a CCAAT motif in pancreatic β-cells. | J Mol Endocrinol | 2024 | 39189982 | PubTator, text mining | PubMed |
| CREB-regulated transcription during glycogen synthesis in astrocytes. | Sci Rep | 2024 | 39095513 | PubTator, text mining | PubMed |
| TORC2 is required for the accumulation of γH2A in response to DNA damage. | J Biol Chem | 2024 | 38971312 | PubTator, text mining | PubMed |
| Hypomethylation-enhanced CRTC2 expression drives malignant phenotypes and primary resistance to immunotherapy in hepatocellular carcinoma. | iScience | 2024 | 38770131 | PubTator, text mining | PubMed |
| Dysfunction of Avo3, an essential component of target of rapamycin complex 2, induces ubiquitin-proteasome-dependent downregulation of Avo2 in Saccharomyces cerevisiae. | Biochem Biophys Res Commun | 2024 | 38718572 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/200186/papers?page=2